-
Firefly Luciferase mRNA: From Signal to Decision
2026-09-18
Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) is more than a bright reporter: it can help separate delivery, transcript integrity, and translation in modern RNA experiments. This guide connects molecular design with LNP formulation evidence to improve gene expression assays, cell viability assays, and in vivo imaging decisions.
-
LRRC8A–Caveolin-1 Signaling in PDAC
2026-09-18
The reference study identifies a cholesterol-dependent LRRC8A–Caveolin-1 complex that connects volume regulation with KRAS/EGFR signaling, ribosome biogenesis, and pancreatic ductal adenocarcinoma growth. Its combined genetic, pharmacological, organoid, xenograft, and proteomic design provides a framework for studying how membrane organization supports biosynthetic expansion in cancer cells.
-
Firefly Luciferase mRNA: Workflow & Optimization
2026-09-17
Build reproducible transfection, gene expression, cell viability, and in vivo imaging workflows with a stabilized, modified firefly reporter transcript. Practical controls and troubleshooting guidance help distinguish RNA delivery, translation, formulation, and cell-health effects.
-
Firefly Luciferase mRNA as a Translational Bridge
2026-09-17
How a chemically modified luciferase transcript can connect assay rigor, LNP characterization, and emerging delivery strategies without confusing reporter signal with therapeutic efficacy.
-
P2RX1, CaMKII, and Mitochondrial Apoptosis in Ph+ ALL
2026-09-16
Li et al. identify P2RX1 as a regulator of tyrosine kinase inhibitor responses in Philadelphia chromosome-positive acute lymphoblastic leukemia, linking excessive purinergic signaling to calcium imbalance, CaMKII activation, PI3K/Akt suppression, and mitochondrial apoptosis. The work provides a mechanistic framework for studying treatment sensitivity while highlighting the need to distinguish prognostic association from therapeutic causality.
-
MTSEA-biotin for Cysteine Accessibility Assays
2026-09-16
MTSEA-biotin enables covalent, affinity-assisted analysis of accessible cysteine residues. This guide connects thiol-reactive labeling with the RNAPII phosphorylation landscape revealed by FeaSion, helping researchers choose orthogonal assays without confusing structural accessibility with phosphorylation state.
-
TMEM16F Lipid Scrambling in Ferroptosis and Immunity
2026-09-15
Yang et al. identify TMEM16F-mediated phospholipid scrambling as a late-stage suppressor of ferroptosis that protects the plasma membrane from collapse. The study further shows that disabling this membrane-remodeling response can increase tumor immunogenicity and improve the effect of PD-1 blockade, providing a mechanistic link between ferroptotic membrane damage and immune rejection.
-
Nuclear cGAS Restricts L1 Retrotransposition
2026-09-15
The reference study identifies a nuclear cGAS–CHK2–TRIM41 pathway that limits LINE-1 retrotransposition by promoting ubiquitination and degradation of the L1 ORF2p protein. Its findings connect DNA damage signaling, post-translational protein control, and genome integrity, while providing a framework for interpreting L1 regulation in senescence and cancer biology.
-
Separating Growth Inhibition from Cell Death in Cancer
2026-09-14
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a more precise framework for distinguishing proliferative arrest from true cell killing, improving interpretation of dose–response experiments and translational cancer research workflows.
-
GI Microjet Delivery of mRNA-LNPs in Mice and Pigs
2026-09-14
The reference study shows that ingestible microjet devices can deliver mRNA-loaded lipid nanoparticles into gastric and intestinal tissue, producing measurable expression and biodistribution in both mice and minipigs. Its central contribution is evidence that gastrointestinal wall administration generates route-dependent exposure in plasma and lymph nodes, supporting further evaluation of needle-free delivery for mRNA therapeutics.
-
P2RX1-Driven Mitochondrial Apoptosis in Ph+ ALL
2026-09-13
The reference study identifies P2RX1 as a regulator of tyrosine kinase inhibitor sensitivity in Philadelphia chromosome-positive acute lymphoblastic leukemia, linking excessive purinergic signaling to calcium/CaMKII activation, PI3K/Akt suppression, mitochondrial dysfunction, and intrinsic apoptosis. Its integrated molecular and functional design provides a framework for connecting pathway changes with measurable cell-death phenotypes in Ph+ ALL models.
-
Verteporfin Beyond PDT: A Mechanobiology Framework
2026-09-12
Verteporfin and CL 318952 can be interpreted through a mechanobiology lens that separates light-dependent cytotoxicity, autophagy inhibition, and cancer-cell stiffness. This guide connects Verteporfin assay design with the MRTFA–KCNMB1 findings that link ionic regulation to metastatic immune evasion.
-
Intravesical p21 mRNA–LNP Therapy in Bladder Cancer
2026-09-11
A 2026 FASEB Journal study developed chemically modified p21 mRNA packaged in lipid nanoparticles for catheter-based bladder delivery. The approach restored nuclear p21, inhibited tumor-cell proliferation, and reduced orthotopic bladder tumor growth while limiting systemic exposure, supporting localized tumor suppressor replacement as a translational strategy.
-
KN-62: A Causal CaMKII Assay Design Guide
2026-09-11
KN-62 is a selective CaMKII inhibitor for separating kinase-dependent signaling from upstream calcium-channel effects. This guide combines product chemistry, secretion and metabolism data, cell-cycle biology, and a calcium-channel reference study to build more discriminating assays.
-
Firefly Luciferase mRNA: Assay Workflows
2026-09-10
Build more reproducible transfection, gene expression, and cell viability workflows with a modified, ARCA-capped luciferase transcript. This guide connects practical assay setup with delivery lessons from recent mRNA vaccine research, while clearly separating validated product characteristics from optimization recommendations.